| 000 | 01009 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513065601.0 | ||
| 264 | 0 | _c19931201 | |
| 008 | 199312s 0 0 eng d | ||
| 022 | _a0028-4793 | ||
| 024 | 7 |
_a10.1056/NEJM199311253292218 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAshby, B L | |
| 245 | 0 | 0 |
_aAerosolized tobramycin in patients with cystic fibrosis. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cNov 1993 |
||
| 300 |
_a1659-60 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 | _aAerosols |
| 650 | 0 | 4 |
_aCystic Fibrosis _xdrug therapy |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPseudomonas _xdrug effects |
| 650 | 0 | 4 |
_aTobramycin _xpharmacology |
| 650 | 0 | 4 |
_aXanthomonas _xdrug effects |
| 700 | 1 | _aStern, D H | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 329 _gno. 22 _gp. 1659-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJM199311253292218 _zAvailable from publisher's website |
| 999 |
_c8231735 _d8231735 |
||